N-[5-[3-(7-piperidin-1-yl-1H-imidazo[4,5-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide
C30H26N8O — CID 137134001
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[5-[3-(7-piperidin-1-yl-1H-imidazo[4,5-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide
N-[5-[3-(7-piperidin-1-yl-1H-imidazo[4,5-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide (PubChem CID 137134001) has the molecular formula C30H26N8O and a molecular weight of 514.59 g/mol. Its IUPAC name is N-[5-[3-(7-piperidin-1-yl-1H-imidazo[4,5-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide.
Molecular Properties
| Compound Name | N-[5-[3-(7-piperidin-1-yl-1H-imidazo[4,5-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide |
|---|---|
| PubChem CID | 137134001 |
| Molecular Formula | C30H26N8O |
| Molecular Weight | 514.59 g/mol |
| Exact Mass | 514.22 |
| IUPAC Name | N-[5-[3-(7-piperidin-1-yl-1H-imidazo[4,5-b]pyridin-2-yl)-1H-indazol-5-yl]-3-pyridinyl]benzamide |
| SMILES | O=C(Nc1cncc(-c2ccc3[nH]nc(-c4nc5nccc(N6CCCCC6)c5[nH]4)c3c2)c1)c1ccccc1 |
| InChI | InChI=1S/C30H26N8O/c39-30(19-7-3-1-4-8-19)33-22-15-21(17-31-18-22)20-9-10-24-23(16-20)26(37-36-24)29-34-27-25(11-12-32-28(27)35-29)38-13-5-2-6-14-38/h1,3-4,7-12,15-18H,2,5-6,13-14H2,(H,33,39)(H,36,37)(H,32,34,35) |
| InChIKey | QQYTUFPSDOGYHV-UHFFFAOYSA-N |
| XLogP | 5.81 |
| TPSA | 115.48 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 514.59 |
| LogP ≤ 5 | 5.81 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 137134001 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.